Paired Microparticles for Reducing Background Binding in Ligand Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ligand binding assays face challenges in achieving high sensitivity and specificity due to background binding signals in biological samples, which can lead to false positive or false negative results, especially when detecting low levels of analytes or biomarkers in complex matrices.
Innovation Solution
The use of capture microparticles and control microparticles, each with specific substrates and capture agents, allows for the differentiation of detection signals and internal reference signals, enabling the subtraction of background noise and improving the accuracy of analyte detection through a self-calibrated method.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional ligand binding assays are used to detect analytes in biological samples, then the assay can identify target molecules, but background binding signals reduce measurement precision and lead to false positive or false negative results
Solution Approach 1:
The assay is segmented into distinct functional components: capture microparticles with capture agents for specific analyte binding, control microparticles without capture agents for background signal measurement, and detection agents for signal generation. This segmentation allows separate measurement and subtraction of background signals from specific analyte signals, improving measurement precision by isolating the harmful background binding effects.
Solution Approach 2:
Control microparticles serve as an intermediary element that measures background binding signals without capturing target analytes. These control microparticles mediate the separation between specific and non-specific binding by providing a reference measurement that can be subtracted from the total signal, thereby eliminating the harmful effect of background binding on measurement accuracy.
2Measurement precision
If high sensitivity methods are used to detect low levels of analytes, then detection capability improves, but background signals increase causing false positives and reducing specificity
Solution Approach 1:
The assay incorporates feedback through control microparticles that provide real-time measurement of background binding signals. This feedback mechanism allows the system to automatically compensate for background interference by subtracting control signals from capture particle signals, enabling high sensitivity detection while maintaining reliability through continuous background correction that prevents false positives.
3Reliability
If solid phase ligand binding assays are used to improve specificity, then target molecule identification improves, but background binding from matrix factors complicates detection and reduces sensitivity
Solution Approach 1:
The solid phase assay is segmented into capture microparticles functionalized with specific capture agents for target analytes and control microparticles lacking capture agents. This segmentation enables differential measurement where control particles quantify background binding from matrix factors while capture particles measure total binding, allowing subtraction of background to improve sensitivity without compromising the specificity provided by solid phase binding.
Solution Approach 2:
Different local qualities are assigned to different microparticle populations: capture microparticles have high specificity for target analytes through capture agent functionalization, while control microparticles have non-specific binding properties that match the background characteristics. This local quality differentiation allows simultaneous measurement of specific and non-specific binding, improving sensitivity through background subtraction while maintaining the specificity of solid phase assays.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the sensitivity, specificity, and accuracy of analyte detection by effectively removing non-specific binding signals, allowing for precise quantification and presence/absence determination of analytes in biological samples.
Implementation Method 1
the internal reference signals emitted by the substrate in the microparticle
Implementation Method 2
Ligand binding assay (LBA) is an analytic detection procedure, which relies on the binding of ligand molecules to receptors, antibodies or other macromolecules
Data Source
AI summary
Methods and kits for accurately detecting one or more analytes in a sample by removing non-specific binding signals utilizing capture and control microparticles. The capture microparticles can specifically bind to the analyte while the control microparticles do not specifically bind to the analyte but to the background molecules. Both capture and control microparticles are added to the sample under suitable conditions to allow binding between analytes and the microparticles. Detection agent is then added to bind to analytes and other substances captured by the microparticles. The microparticles are then run through a cytometry-based detection method, where detection signals from the capture and the control microparticles are distinguished. The differences between the detection signals from the capture and the control microparticles are obtained, which are then used to determine the presence and/or amounts of the analytes based on a previously determined relationship between such differences and known amount of the analyte.